Control-IQ Technology Use in Individuals With High Insulin Requirements: Results From the Multicenter Higher-IQ Trial.

Anders L CarlsonTimothy E GrahamHalis Kaan AkturkDavid R LiljenquistRichard M BergenstalBecky SulikViral N ShahMark SulikPeter ZhaoPeter BriggsRavid Sassan-KatchalskiJordan E Pinsker

Published in: Journal of diabetes science and technology (2024)

Control-IQ technology version 1.5, with wider range of weight and TDI input and enhancements for users with high insulin requirements, was safe in individuals with T1D in this study.

Keyphrases

type diabetes
glycemic control
clinical trial
physical activity
body mass index
study protocol
phase iii
phase ii
metabolic syndrome
weight gain
adipose tissue
psychometric properties
insulin resistance
open label